Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trajectories of FEV1 After Lung Transplantation: Determinants and Clinical Outcomes

NCT05934617 is registered in ClinicalTrials.gov with Paris Translational Research Center for Organ Transplantation as lead sponsor.

NCT NCT05934617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05934617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trajectories of FEV1 After Lung Transplantation: Determinants and Clinical Outcomes
Lead sponsor
Paris Translational Research Center for Organ Transplantation
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2020
Completion date
July 1, 2024
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lung allograft dysfunction, lung transplant failure and rejection